Prof Dr. Daling Zhu | Genetics and Molecular Biology | Best Researcher Award

Prof Dr. Daling Zhu, Harbin Medical University, China

 Profile

Scopus

OrcID

📚 Early Academic Pursuits

Professor Daling Zhu is an eminent scholar with a profound background in medical research and academia. He has a distinguished career beginning with his appointment as a PhD Supervisor and Postdoctoral Cooperative Supervisor.

💼 Professional Endeavors

Daling Zhu holds several prestigious titles, including the first batch of “Longjiang Scholars” distinguished professors. He has been recognized as an expert with special allowances from both national and Heilongjiang provincial governments and has been acknowledged as an outstanding middle-aged and young expert in Heilongjiang Province. He has held notable positions such as the Director of the Department of Pharmacy at the Second Affiliated Hospital of Harbin Medical University, Dean of the School of Pharmacy, and President of the Daqing Campus.

🔬CONTRIBUTIONS AND RESEARCH FOCUS

  • Professor Daling Zhu has significantly contributed to the field of pulmonary hypertension through his extensive research efforts. He has successfully undertaken and completed 35 scientific research projects, including a major research project of the National Natural Science Foundation of China, the National Natural Science Foundation of China Foreign Exchange and Cooperation Project, sub-projects of the “863” project, and the National Science and Technology Research Program (973) – sub-project of the China Human Liver Proteome Program. Additionally, he has led a project for the American College of Cardiology and various major provincial and municipal projects. His research has earned him numerous accolades, including second prizes for outstanding achievements in scientific research from the Ministry of Education and a first prize for natural science from the Heilongjiang Provincial Government. These contributions have advanced the understanding and treatment of pulmonary hypertension, highlighting Professor Zhu’s role as a leading figure in medical research.

🌟Impact and Influence

  • Professor Daling Zhu’s work has had a profound impact on the field of pulmonary hypertension and beyond. His extensive research has led to critical advancements in understanding the molecular mechanisms of this condition, resulting in improved early diagnosis and treatment strategies. The recognition of his contributions is evident through numerous prestigious awards, including second prizes for outstanding scientific research achievements from the Ministry of Education and a first prize for natural science from the Heilongjiang Provincial Government. With 167 SCI-indexed articles published in prominent foreign academic journals, his research has gained significant global recognition, influencing peers and guiding future studies in the field. Professor Zhu’s contributions continue to shape the landscape of medical research, making a lasting impact on both the scientific community and patient care.

🔬 RESEARCH FOCUS

Professor Zhu is primarily engaged in research on the pathogenesis of pulmonary hypertension and the identification of early diagnosis and treatment targets. His work has significantly advanced the understanding of molecular mechanisms underlying this condition.

📖 ACADEMIC CITES

Professor Zhu has published 167 SCI-indexed articles in foreign academic journals, demonstrating his prolific contribution to scientific literature and his research’s global impact.

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Through his extensive research and numerous publications, Professor Zhu has cemented his legacy in the scientific community. His future contributions will continue to influence the field of pulmonary hypertension, providing critical insights and advancements in diagnosis and treatment.

📰PUBLICATIONS

    • 1. SP1 undergoes phase separation and activates RGS20 expression through super-enhancers to promote lung adenocarcinoma progression

      • Authors: Shan, L., Wang, W., Du, L., Sui, G., Liu, F.
      • Journal: Proceedings of the National Academy of Sciences of the United States of America, 2024, 121(29), e2401834121

      2. Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular Remodeling

      • Authors: Shen, T., Shi, J., Zhao, X., Liu, P., Zhu, D.
      • Journal: American Journal of Respiratory Cell and Molecular Biology, 2024, 70(6), pp. 468–481

      3.Super enhancer-associated circRNA-circLrch3 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis by formation of R-loop with host gene

        • Authors: Liu, H., Jiang, Y., Shi, R., Zheng, X., Zhu, D.
        • Journal: International Journal of Biological Macromolecules, 2024, 268, 130853

      4. Erratum: lnc-Rps4l-encoded peptide RPS4XL regulates RPS6 phosphorylation and inhibits the proliferation of PASMCs caused by hypoxia (Molecular Therapy (2021) 29(4) (1411–1424), (S1525001621000058), (10.1016/j.ymthe.2021.01.005))

      • Authors: Li, Y., Zhang, J., Sun, H., Shi, W., Zhu, D.
      • Journal: Molecular Therapy, 2024

      5. Super Enhancer-Associated Circular RNA-CircKrt4 Regulates Hypoxic Pulmonary Artery Endothelial Cell Dysfunction in Mice

      • Authors: Ma, C., Wang, X., Zhang, L., Qu, L., Zhu, D.
      • Journal: Arteriosclerosis, Thrombosis, and Vascular Biology, 2023, 43(7), pp. 1179–1198
Prof Dr. Daling Zhu | Genetics and Molecular Biology | Best Researcher Award | 1164